What other stocks do shareholders of Alterity Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alterity Therapeutics investors own include Novavax (NVAX) , Catalyst Pharmaceuticals (CPRX) , Intercept Pharmaceuticals (ICPT) , Rigel Pharmaceuticals (RIGL) , Arena Pharmaceuticals (ARNA) , Conatus Pharmaceuticals (CNAT) , Gilead Sciences (GILD) , GW Pharmaceuticals (GWPH) , Inovio Pharmaceuticals (INO) and Microbot Medical (MBOT) .

NASDAQ:PRAN

Alterity Therapeutics (PRAN) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free PRAN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $1.97
▼
$2.16
50-Day Range: $0.95
▼
$2.06
52-Week Range: $1.09
▼
$2.91

Volume: 25,391 shs
Average Volume: 130,956 shs
Market Capitalization: $19.05 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Alterity Therapeutics alerts:

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

About Alterity Therapeutics Stock (NASDAQ:PRAN)

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Ad DTI

Special FREE offer on stock hotsheets

Click here and I’ll show you

PRAN Stock News Headlines

April 18, 2024 | finance.yahoo.com

Kazia Therapeutics Limited (KZIA)

December 21, 2023 | nasdaq.com

Alterity Therapeutics Says Phillip Hains To Replace Kathryn Andrews As CFO

April 18, 2024 | WealthPress (Ad)

Chances are you know the firms on this list

These are the entities that can buy MILLIONS of shares in a single day… I’m talking about huge orders that literally move the share price 1%, 2%, even 5% or more in the process. Why am I showing you that list? Well, because if you have a way to successfully detect which stocks these elite traders are likely buying in real time… All you have to do is ride the coattails of their massive orders and you can target endless trading opportunities without leaving your money exposed to the markets for too long. And in case you didn’t already know…

December 21, 2023 | markets.businessinsider.com

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

December 4, 2023 | seekingalpha.com

Alterity jumps after promising data on Parkinson's candidate

December 4, 2023 | investorplace.com

Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?

October 31, 2023 | morningstar.com

Axsome Therapeutics Inc AXSM

October 8, 2023 | morningstar.com

ADRs End Higher; Orchard Therapeutics PLC Climbs 96%

April 18, 2024 | WealthPress (Ad)

Chances are you know the firms on this list

August 23, 2023 | technews.tmcnet.com

Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson's and Alzheimer's

March 14, 2023 | technews.tmcnet.com

Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer's Disease

January 30, 2023 | marketwatch.com

Alterity: Study Shows ATH434 Prevents Loss of Brain Cells in Parkinson's Disease Animal Model

September 26, 2022 | benzinga.com

Alterity Therapeutics Stock (OTC:PRNAF), Analyst Ratings, Price Targets, Predictions

September 20, 2022 | msn.com

Here's Why Alterity Therapeutics Shares Are Volatile

See More Headlines

Receive PRAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:PRAN
CUSIP: N/A
CIK: 1131343
Web: www.pranabio.com
Phone: (139) 349-4906
Fax: N/A
Employees: 14
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.37
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $150,000.00
Price / Sales: 119.26
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.40 per share
Price / Book: 1.44

Miscellaneous

Outstanding Shares: 8,900,000
Free Float: N/A
Market Cap: $17.89 million
Optionable: Not Optionable
Beta: 1.05

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Geoffrey Paul Kempler
Executive Chairman & Chief Executive Officer
Kathryn J. E. Andrews
Chief Financial Officer
David A. Stamler
Chief Medical Officer & SVP-Clinical Development
Phillip Allen Hains
Secretary

Key Competitors

View All Competitors

PRAN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Alterity Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alterity Therapeutics investors own include Novavax (NVAX), Catalyst Pharmaceuticals (CPRX), Intercept Pharmaceuticals (ICPT), Rigel Pharmaceuticals (RIGL), Arena Pharmaceuticals (ARNA), Conatus Pharmaceuticals (CNAT), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH), Inovio Pharmaceuticals (INO) and Microbot Medical (MBOT).

This page (NASDAQ:PRAN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alterity Therapeutics (PRAN) Stock Price, News & Analysis

About Alterity Therapeutics Stock (NASDAQ:PRAN)

PRAN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PRAN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info